STRATA Skin Sciences (NASDAQ:SSKN) Announces Quarterly Earnings Results, Misses Estimates By $0.01 EPS

STRATA Skin Sciences (NASDAQ:SSKNGet Rating) released its quarterly earnings data on Wednesday. The medical device company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.01), MarketWatch Earnings reports. STRATA Skin Sciences had a negative net margin of 8.85% and a negative return on equity of 18.46%. During the same quarter last year, the company earned ($0.07) earnings per share. STRATA Skin Sciences updated its FY 2022 guidance to EPS.

Shares of NASDAQ SSKN traded up $0.04 during mid-day trading on Thursday, hitting $1.08. The company had a trading volume of 34,866 shares, compared to its average volume of 34,456. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.56 and a quick ratio of 1.29. The company has a market capitalization of $37.50 million, a PE ratio of -13.63 and a beta of 1.93. STRATA Skin Sciences has a 1-year low of $1.03 and a 1-year high of $1.95. The business’s 50-day simple moving average is $1.40 and its 200 day simple moving average is $1.49.

Separately, Zacks Investment Research lowered STRATA Skin Sciences from a “hold” rating to a “sell” rating in a report on Tuesday, May 3rd.

In other news, CEO Robert Joseph Moccia bought 33,300 shares of the firm’s stock in a transaction on Thursday, March 24th. The stock was purchased at an average price of $1.57 per share, for a total transaction of $52,281.00. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 37.33% of the company’s stock.

A hedge fund recently bought a new stake in STRATA Skin Sciences stock. PNC Financial Services Group Inc. purchased a new position in STRATA Skin Sciences, Inc. (NASDAQ:SSKNGet Rating) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 31,733 shares of the medical device company’s stock, valued at approximately $47,000. PNC Financial Services Group Inc. owned about 0.09% of STRATA Skin Sciences as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 37.50% of the company’s stock.

STRATA Skin Sciences Company Profile (Get Rating)

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.

See Also

Earnings History for STRATA Skin Sciences (NASDAQ:SSKN)

Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with's FREE daily email newsletter.